| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
long intergenic non-protein coding RNA 963 | 0.700 | 0.269 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
GAS6 divergent transcript | 0.821 | 0.154 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
DSCAM antisense RNA 1 | 0.722 | 0.346 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
testis associated oncogenic lncRNA | 0.716 | 0.308 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
colon cancer associated transcript 1 | 0.585 | 0.500 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
transmembrane protein 178B | 1.000 | 0.038 | 0.95 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
RBM14-RBM4 readthrough | 0.647 | 0.615 | 0.98 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
TMX2-CTNND1 readthrough (NMD candidate) | 0.538 | 0.769 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | |||||||||
|
BCL2L2-PABPN1 readthrough | 0.653 | 0.500 | 0.28 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
endogenous retrovirus group K member 2 | 0.674 | 0.423 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | |||||||||
|
microRNA 203b | 1.000 | 0.038 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
endogenous retrovirus group K member 12 | 0.678 | 0.423 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | |||||||||
|
endogenous retrovirus group K member 22 | 0.678 | 0.423 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | |||||||||
|
secretory carrier membrane protein 3 | 0.890 | 0.077 | 2.2E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
H3 histone pseudogene 12 | 0.603 | 0.615 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1998 | 1998 | |||||||||
|
hepatocellular carcinoma up-regulated EZH2-associated long non-coding RNA | 0.722 | 0.269 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
endogenous retrovirus group K member 11 | 0.663 | 0.423 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | |||||||||
|
long intergenic non-protein coding RNA 459 | 1.000 | 0.038 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
cadherin 11 | 0.512 | 0.808 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
actin related protein 2/3 complex subunit 1B | 0.736 | 0.346 | 1.1E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
FOXD3 antisense RNA 1 | 0.743 | 0.192 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
PGR antisense RNA 1 | 0.514 | 0.808 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | |||||||||
|
opsin 1, medium wave sensitive 3 | 0.601 | 0.769 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
kinesin family member 20A | 0.615 | 0.615 | 4.5E-13 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
A-kinase anchoring protein 9 | 0.638 | 0.385 | 4.5E-17 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 |